BioCentury
ARTICLE | Company News

Management tracks

April 25, 2017 11:33 PM UTC

Eye disease company Ophthotech Corp. (NASDAQ:OPHT) said co-founder and CEO David Guyer will become executive chairman, effective July 1. President and CFO Glenn Sblendorio will become CEO and remain president. Ophthotech promoted SVP of Finance David Carroll to CFO.

The Mustang Bio Inc. subsidiary of Fortress Biotech Inc. (NASDAQ:FBIO) named Manuel Litchman president and CEO. He was CEO at Arvinas LLC (New Haven, Conn.). Mustang develops chimeric antigen receptor (CAR) T cell therapies...